JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $27
JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.
Read original at benzingaStocks · News reference
Gentex Affirms FY2026 Sales Guidance of $2.650B-$2.750B vs $2.692B Est
Gentex (NASDAQ:GNTX) affirms FY2026 sales outlook from $2.650 billion-$2.750 billion to $2.650 billion-$2.750 billion vs $2.692 billion estimate.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 24, 2026, 12:01 PM
- Checked
- Jul 24, 2026, 12:01 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Gentex Warns China Sales Will Keep Falling Through 2027
Gentex (NASDAQ: GNTX) stock drops on mixed Q2 results: EPS beats estimates, revenue misses. Company reaffirms FY26 and FY27 guidance.
Read original at benzingaGentex shares are trading lower after the company reported mixed Q2 financial results.
Read original at benzingaGentex Affirms FY2027 Sales Guidance of $2.800B-$2.900B vs $2.826B Est
Gentex (NASDAQ:GNTX) affirms FY2027 sales outlook from $2.800 billion-$2.900 billion to $2.800 billion-$2.900 billion vs $2.826 billion estimate.
Read original at benzinga